Literature DB >> 378838

Induction of cell-mediated immunity to Mycobacterium leprae in guinea pigs.

V Mehra, B R Bloom.   

Abstract

Guinea pigs immunized with intact or disrupted armadillo-grown human Mycobacterium leprae administered in aqueous or oil vehicles were tested with various dilutions of M. leprae suspended in saline, water-soluble M. leprae extract, purified protein derivative, and a water-soluble extract of normal armadillo tissue. The results demonstrated the following. (i) Under no conditions was any skin test reactivity found to normal armadillo tissue extract. (ii) Positive sensitization to both M. leprae and its water-soluble extract was achieved by sensitizing guinea pigs with M. leprae suspended in Hanks solution or saline. Autoclaved M. leprae in Hanks solution or saline inoculated intradermally was an effective immunogen. Oil suspensions or emulsions were effective at sensitization, but appeared to be no better and, in general, slightly weaker, than simple inoculation in aqueous suspension. (iii) Living BCG failed to reveal a significant adjuvant effect on sensitization to M. leprae. However, cord factor appeared to potentiate slightly the sensitization to M. leprae in aqueous suspension. (iv) The minimum dose required for sensitization with M. leprae in aqueous suspension was 55 micrograms of purified bacilli. (v) Animals inoculated with M. leprae in saline or with M. leprae together with BCG showed positive skin test reactivity to the first skin test application made fully 1 year after the initial sensitization. The efficacy of autoclaved, irradiated M. leprae in aqueous, oil-free medium suggests a relatively safe approach to human vaccination studies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378838      PMCID: PMC414234          DOI: 10.1128/iai.23.3.787-794.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  Experimental sensitization with particular reference to picryl chloride.

Authors:  M W CHASE
Journal:  Int Arch Allergy Appl Immunol       Date:  1954

2.  Cord factor and related trehalose esters.

Authors:  E Lederer
Journal:  Chem Phys Lipids       Date:  1976-03       Impact factor: 3.329

3.  Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

4.  Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli.

Authors:  A Bekierkunst; I S Levij; E Yarkoni; E Vilkas; E Lederer
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

5.  Heat stability of Mycobacterium leprae immunogenicity.

Authors:  C C Shepard; L L Walker; R van Landingham
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

6.  Induction of cell-mediated immunity to Mycobacterium leprae in mice.

Authors:  P J Patel; M J Lefford
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

7.  A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity.

Authors:  B R Bloom; L Jimenez; P I Marcus
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

  7 in total
  15 in total

1.  Human T-cell clones with reactivity to Mycobacterium leprae as tools for the characterization of potential vaccines against leprosy.

Authors:  F Emmrich; S H Kaufmann
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae.

Authors:  R H Gelber; P J Brennan; S W Hunter; M W Munn; J M Monson; L P Murray; P Siu; M Tsang; E G Engleman; N Mohagheghpour
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects.

Authors:  R E Weir; P J Brennan; C R Butlin; H M Dockrell
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

4.  Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy.

Authors:  A Castells; J Terencio; A Ramirez; E Sundal; K Bolla
Journal:  Surv Immunol Res       Date:  1985

5.  Phenolic glycolipid 1 of Mycobacterium leprae causes nonspecific inflammation but has no effect on cell-mediated responses in mice.

Authors:  S J Brett; C Lowe; S N Payne; P Draper
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

6.  Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae.

Authors:  H K Gill; A S Mustafa; T Godal
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

7.  Immunological significance of Mycobacterium leprae cell walls.

Authors:  J Melancon-Kaplan; S W Hunter; M McNeil; C Stewart; R L Modlin; T H Rea; J Convit; P Salgame; V Mehra; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  Adoptive cell transfer of resistance to Mycobacterium leprae infections in mice.

Authors:  C Lowe; S J Brett; R J Rees
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

9.  Searches among mycobacterial cultures for antileprosy vaccines.

Authors:  C C Shepard; R van Landingham; L L Walker
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

10.  Effect of purification steps on the immunogenicity of Mycobacterium leprae.

Authors:  C C Shepard; P Draper; R J Rees; C Lowe
Journal:  Br J Exp Pathol       Date:  1980-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.